Medmix Ltd
SIX:MEDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Medmix Ltd
Cash from Operating Activities
Medmix Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Medmix Ltd
SIX:MEDX
|
Cash from Operating Activities
CHf67.8m
|
CAGR 3-Years
13%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Metall Zug AG
SIX:METN
|
Cash from Operating Activities
-CHf6.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sonova Holding AG
SIX:SOON
|
Cash from Operating Activities
CHf819.7m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
6%
|
|
|
Medacta Group SA
SIX:MOVE
|
Cash from Operating Activities
€152.7m
|
CAGR 3-Years
28%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
Straumann Holding AG
SIX:STMN
|
Cash from Operating Activities
CHf504m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
Medmix Ltd
Glance View
medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The company is headquartered in Zug, Zug and currently employs 2,101 full-time employees. The firm operates in business areas such as: the dental segment, which provides MIXPAC and transcodent - system solutions that are used to dose, mix and apply various types of dental materials; drug delivery- solutions for the dosage and application of drugs; a surgical segment which provides devices for bone regeneration and tissue healing; an industry segment that specializes in the mixing and dosing of sealants and adhesives through IXPAC , COX and MK; and a beauty segment in which it produces cosmetic applicators through the GEKA brand.
See Also
What is Medmix Ltd's Cash from Operating Activities?
Cash from Operating Activities
67.8m
CHF
Based on the financial report for Dec 31, 2025, Medmix Ltd's Cash from Operating Activities amounts to 67.8m CHF.
What is Medmix Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
6%
Over the last year, the Cash from Operating Activities growth was -22%. The average annual Cash from Operating Activities growth rates for Medmix Ltd have been 13% over the past three years , 6% over the past five years .
